CLINICAL_TRIALS trial_result · 2019-01-23

Clinical Trial Update: Temozolomide in Treating Patients With Low-Grade Glioma [Phase 2]

Phase 2 clinical trial update for temozolomide in patients with low-grade glioma. The study is completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of California, San Francisco | Conditions: CNS Tumor, Adult | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23